HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC Addresses Confusion Over Updated Endorsement Guides

This article was originally published in The Rose Sheet

Executive Summary

One year after the Federal Trade Commission updated its "Guides Concerning the Use of Endorsements and Testimonials in Advertising," there is still confusion surrounding the changes and questions as to how they affect marketers, bloggers and product endorsers

Related Content

Skin 2 Spirit Scrubs Acne Claims On FDA Warning; Moon Valley Psoriasis Claim Persists
FTC Updates Policy For Unmasking 'Native Advertising'
FTC Updates Endorsement Guide Resource: 'What People Are Asking'
P&G, U.K. Ad Authority Clash Over YouTube Channel Disclosures
DERMAdoctor Comparisons To Laser Treatments Unsupported – NAD
Social Media Success Prompts Anti Monkey Butt To Turn Its Back On TV
Evidence Lacking For Bosom Max Claims; ERSP Advises Discontinuation
Look In Existing Regs For Social Media Marketing Guidance, Experts Say
Burt's Defends "Clinically Proven" Toothpaste Claim Against Tom's Challenge
FTC Advises Against Unqualified "Green" Claims, Including Eco-Seals



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts